Latest news
Overcoming Barriers to Intravesical Gemcitabine System in High-Risk NMIBC - CancerNetworkCancerNetwork · Sat, 08 Aug 2026 12:09:17 GMTDurvalumab Plus BCG Improves Outcomes in High-Risk Non–Muscle-Invasive Bladder Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 16:07:30 GMTCG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:23:19 GMTCG Oncology publishes investor deck highlighting cretostimogene data in high-risk NMIBC programs - BitgetBitget · Thu, 06 Aug 2026 05:04:15 GMTRedefining High-Risk NMIBC - EMJEMJ · Sat, 01 Aug 2026 01:07:30 GMTCretostimogene Grenadenorepvec Shows Complete Responses in NMIBC - CancerNetworkCancerNetwork · Tue, 28 Jul 2026 17:08:36 GMTPublished BOND-003 data show durable responses with cretostimogene in NMIBC - Urology TimesUrology Times · Tue, 28 Jul 2026 07:00:00 GMT